Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AvantorAVTR -1.37%69 EV-to-OCF is 21.16 as of Aug. 15, 2026, which is 16% below its 10-year median of 25.07. GuruFocus rates AVTR with a GF Score™ of 69/100 and a GF Value™ of $16.84 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 853 Medical Devices & Instruments companies, Avantor ranks worse than 77.73% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Avantor's Enterprise Value is $12,630 Mil.
Avantor's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was $597 Mil. Therefore, Avantor's EV-to-OCF for today is 21.16.
The historical rank and industry rank for Avantor's EV-to-OCF or its related term are showing as below:
AVTR'
s EV-to-OCF Range Over the Past 10 Years
Min: 13.8 Med: 25.07 Max: 64.5
Current: 21.16
During the past 10 years, the highest EV-to-OCF of Avantor was 64.50. The lowest was 13.80. And the median was 25.07.
AVTR's EV-to-OCF is ranked worse than 77.73% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: 7.94
vs AVTR: 21.16
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
As of today (2026-08-15), Avantor's stock price is $13.66.
Avantor's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was $-0.840. Therefore, Avantor's PE Ratio (TTM) for today is At Loss.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Avantor's share price for today is $13.66.
Avantor's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.840.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Avantor EV-to-OCF Related Terms
Avantor EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Avantor's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Avantor's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Avantor EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Avantor's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Avantor's EV-to-OCF falls into.
Avantor's current Enterprise Value is $12,630 Mil.
Avantor's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $597 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Avantor (AVTR) has a EV-to-OCF of 21.16 as of Aug. 15, 2026. This is 16% below median its historical median of 25.07. Over the past decade, Avantor's EV-to-OCF has ranged from 13.80 to 64.50. According to the industry distribution chart, Avantor ranks #663 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 77.7%.
Is Avantor's EV-to-OCF too high?
Avantor's current EV-to-OCF of 21.16 is 16% below median its 10-year median of 25.07. Over the past 10 years, this metric has ranged from a low of 13.80 to a high of 64.50. The Medical Devices & Instruments industry median EV-to-OCF is 7.94. Avantor's value of 21.16 is 166.5% above this industry median. Based on the distribution chart, Avantor ranks #663 out of 853 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Avantor has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Avantor's EV-to-OCF compare to RGEN and ATR?
According to the Medical Devices & Instruments industry distribution chart, Avantor ranks #663 out of 853 companies for EV-to-OCF. This places Avantor in the lower half of its industry. The industry median EV-to-OCF is 7.94. Avantor's value of 21.16 is 166.5% above this benchmark. Historically, Avantor's own EV-to-OCF has ranged from 13.80 to 64.50 over the past decade. While the company's 10-year median is 25.07 vs. the industry median of 7.94, Avantor has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.94, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Avantor's current EV-to-OCF of 21.16 is 166.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Avantor's current EV-to-OCF is 21.16, which is 16% below median its own 10-year median of 25.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avantor stock overvalued right now?
Based on GuruFocus' analysis, Avantor (AVTR) is currently considered Modestly Undervalued. The stock's GF Value™ is $16.84, compared to a current price of $13.66 — trading 18.9% below its estimated fair value. The current EV-to-OCF is 21.16, which is 16% below median its 10-year median of 25.07 and 166.5% above the Medical Devices & Instruments industry median of 7.94. Avantor's overall GF Score™ is 69/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Avantor (AVTR), the current EV-to-OCF is 21.16 as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Avantor (AVTR) Overvalued in 2026?
Based on GuruFocus' analysis, Avantor stock appears to be undervalued.
The current stock price of $13.66 is trading 18.9% below its estimated GF Value™ of $16.84.
GuruFocus considers Avantor to be Modestly Undervalued.
Key valuation signals for AVTR:
EV-to-OCF: 21.16 (16% below median its 10-year median of 25.07)
GF Value™: $16.84 vs. price of $13.66 (18.9% below fair value)
Industry Position: 166.5% above the Medical Devices & Instruments median (#663 of 853)
No single metric tells the full story. See the AVTR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Avantor Inc provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates through two segments: Laboratory Solutions and Bioscience Production. It offers materials & consumables, equipment & instrumentation, and services & specialty procurement. Product groups include Equipment & Instrumentation, Services & Specialty Procurement, Proprietary Materials & Consumables, and Third-Party Materials & Consumables. Materials & consumables include high-purity chemicals and reagents, lab supplies, customized excipients, single-use assemblies, chromatography products, sample preparation kits, and fluid handling solutions. It operates in the Americas, Europe, and AMEA.
69GF Score
Get the complete analysis for AVTR
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AVTR has been successfully added to your 
